PAG
CANF

Private Advisor Group’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Private Advisor Group’s Portfolio CANF Stock Details CANF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10
Closed -$4K – 1830
2020
Q2 		$4K Buy
+10
New +$3.68K ﹤0.01% 3310

Other funds holding CANF

SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Private Advisor Group's CANF Position: Q3 2020 in Review

Private Advisor Group sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q3 2020, closing a stake of 10 shares — an estimated $4K sold.

Private Advisor Group first reported a position in CANF in Q2 2020 and held it in 1 quarter. The position peaked at $4K in Q2 2020. 9 funds tracked by Wall St. Rank hold CANF as of Q3 2020.

  • Private Advisor Group reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q3 2020 after selling out during the quarter.
  • Private Advisor Group sold 10 Can-Fite BioPharma American Depositary Shares shares in Q3 2020, an estimated $4K.
  • Private Advisor Group first reported a position in Can-Fite BioPharma American Depositary Shares in Q2 2020 and held it in 1 quarter.
  • Private Advisor Group's Can-Fite BioPharma American Depositary Shares position peaked at $4K in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.